Phreesia, Inc.

Phreesia, Inc.

PHR·NYSE

$9.90

-4.4%
HealthcareMedical - Healthcare Information Services

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

At a Glance

Live Snapshot
Market Cap$612.25M
EPS0.0386
P/E Ratio256.61
Earnings Date09/03/2026

phr

Inventory

Last Annual Value

0.00

3-Year CAGR

%

5-Year CAGR

%

10-Year CAGR

%

Phreesia, Inc.

Phreesia, Inc. Competitors Analysis of Inventory

PHR · NYSE
CompanyInventory
CAGR 3Y
CAGR 5Y
CAGR 10Y
0.00
N/AN/AN/A 
30.16M
-11.5%1.2%32.9%
0.00
N/AN/AN/A
NVCR logo
NovoCure Limited
NASDAQ:NVCR
0.00
N/AN/AN/A
0.00
N/AN/AN/A
OMDA logo
Omada Health
NASDAQ:OMDA
4.49M
7.5%N/AN/A
6.57M
46.0%N/AN/A
OMCL logo
Omnicell, Inc.
NASDAQ:OMCL
100.91M
-2.9%-3.4%3.8%
190.86M
12.6%13.6%11.5%
38.20M
9.0%-12.2%N/A
Phreesia, Inc.

Phreesia, Inc. Fair Value Envelope

PHR · NYSE

Our analysis suggests that PHR has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $9.905, this represents a potential HIDDEN relative to our calculated worth for Phreesia, Inc..

Intrinsic Value
Current Price: $9.905